These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33787865)

  • 21. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to statins in primary prevention: yearly adherence changes and outcomes.
    Slejko JF; Ho M; Anderson HD; Nair KV; Sullivan PW; Campbell JD
    J Manag Care Pharm; 2014 Jan; 20(1):51-7. PubMed ID: 24372460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.
    Talic S; Marquina C; Ofori-Asenso R; Petrova M; Liew D; Owen AJ; Lybrand S; Thomson D; Ilomaki J; Zomer E; Ademi Z
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):867-877. PubMed ID: 34097194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).
    Rehman H; Ahmed ST; Akeroyd J; Mahtta D; Jia X; Rifai MA; Nasir K; Jneid H; Khalid MU; Alam M; Toth PP; Virani SS
    Am J Cardiol; 2019 Oct; 124(8):1165-1170. PubMed ID: 31405545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
    J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.
    Ahmed ST; Mahtta D; Rehman H; Akeroyd J; Al Rifai M; Rodriguez F; Jneid H; Nasir K; Samad Z; Alam M; Petersen LA; Virani SS
    Am Heart J; 2020 Mar; 221():9-18. PubMed ID: 31896038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy.
    Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV
    J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin Adherence and Mortality in Patients Aged 80 Years and Older After Acute Myocardial Infarction.
    Phan DQ; Duan L; Lam B; Hekimian A; Wee D; Zadegan R; Lee MS
    J Am Geriatr Soc; 2019 Oct; 67(10):2045-2049. PubMed ID: 31206603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
    Mahtta D; Lee MT; Ramsey DJ; Akeroyd JM; Krittanawong C; Khan SU; Sinh P; Alam M; Garratt KN; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):93-102. PubMed ID: 33400053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases.
    Choi SY; Yang BR; Kang HJ; Park KS; Kim HS
    Korean J Intern Med; 2020 May; 35(3):593-604. PubMed ID: 31752475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Giacobbe F; Giannino G; Annone U; Morena A; Di Vita U; Carmagnola L; Nebiolo M; Rollo C; Ravetti E; Troncone M; Pancotti C; De Filippo O; Bruno F; Angelini F; Gaido L; Fariselli P; D'Ascenzo F; Giammaria M; De Ferrari GM
    Int J Cardiol; 2024 Jun; 405():131933. PubMed ID: 38437950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of statin use and long-term adherence and persistence among older adults with diabetes.
    Ofori-Asenso R; Ilomäki J; Tacey M; Zomer E; Curtis AJ; Bell JS; Zoungas S; Liew D
    J Diabetes; 2018 Sep; 10(9):699-707. PubMed ID: 29658177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.
    Lucas JE; Bazemore TC; Alo C; Monahan PB; Voora D
    PLoS One; 2017; 12(11):e0187809. PubMed ID: 29155848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article).
    Hyun MH; Jang JW; Choi BG; Na JO; Choi CU; Kim JW; Kim EJ; Rha SW; Park CG; Lee E; Seo HS
    Medicine (Baltimore); 2019 Dec; 98(51):e18510. PubMed ID: 31861037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.
    Guglielmi V; Bellia A; Pecchioli S; Della-Morte D; Parretti D; Cricelli I; Medea G; Sbraccia P; Lauro D; Cricelli C; Lapi F
    Atherosclerosis; 2017 Aug; 263():36-41. PubMed ID: 28599257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.
    Jia X; Al Rifai M; Ramsey DJ; Ahmed ST; Akeroyd JM; Nambi V; Ballantyne CM; Petersen LA; Stone NJ; Virani SS
    Am J Med; 2019 Sep; 132(9):e693-e700. PubMed ID: 31103643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients: estimates from Swedish population-based registry data.
    Banefelt J; Lindh M; Svensson MK; Eliasson B; Tai MH
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):323-331. PubMed ID: 32239140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.